NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $309,718 | -92.1% | 3,414 | -93.4% | 0.03% | -92.2% |
| Q3 2022 | $3,916,000 | -9.9% | 51,562 | +1.8% | 0.44% | +2.1% |
| Q2 2022 | $4,348,000 | -3.5% | 50,632 | -1.4% | 0.43% | +1.9% |
| Q1 2022 | $4,506,000 | -12.8% | 51,333 | -10.0% | 0.42% | -9.9% |
| Q4 2021 | $5,167,000 | +16.1% | 57,062 | +6.8% | 0.47% | +18.2% |
| Q3 2021 | $4,452,000 | -8.3% | 53,427 | +0.4% | 0.40% | -18.7% |
| Q2 2021 | $4,855,000 | +6.4% | 53,206 | -0.3% | 0.49% | -5.8% |
| Q1 2021 | $4,561,000 | +6.1% | 53,363 | +17.3% | 0.52% | -9.2% |
| Q4 2020 | $4,297,000 | +16.1% | 45,506 | +7.7% | 0.57% | +0.4% |
| Q3 2020 | $3,700,000 | +30.7% | 42,271 | +32.1% | 0.57% | +18.2% |
| Q2 2020 | $2,831,000 | +6.3% | 32,007 | -1.0% | 0.48% | -34.7% |
| Q1 2020 | $2,664,000 | -11.3% | 32,314 | +1.9% | 0.73% | +12.1% |
| Q4 2019 | $3,002,000 | – | 31,701 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |